Literature DB >> 20387483

[Hepatitis viruses infection situation in human population of the Gansu province].

Jian Lu1, Hong-yu Li, Rui-guang Tian, Yong-zhen Jiang, Ya-ning Xu, De-shan Yu, Jian-xiang Jiang, Sheng-li Bi.   

Abstract

OBJECTIVE: To investigate the seroprevalence of hepatitis viruses in human population of Ganso province.
METHODS: ELISA was used for detecting anti-HAY IgG, HBsAg/HBsAb, anti-HCV IgG and anti-HEV IgG of the serum samples. All sample were collected in four areas of KL, LT, HN and ZhL of Gansu province in 2008.
RESULTS: 1977 samples were detected, The positive rates of anti-HAY, HBsAg/HBsAh, anti-HCV, and anti-HEY are 84.57% (1672/1977), 4.81% (95/1977) and 28.73% (568/1977), 0.46% (9/1977),and 13.10% (259/1977), respectively. The positive rate at different age group, for anti-HAY was 43.21% of c 9 years old, 80.23% of 10-19 years old, 93.02% of 20-29 years old, 95.55% of 30-39 years old, 95.60%-97.52% of 40-60 years old. For HBsAg/HBsAb were 2.09% or 29.27%, 3.02% or 21.81%, 6.20% or 36.43%, 5.93% or 31.16%, 6.43% or 3l.43%, 7.32% or 24.88%, 3.33% or 28.89% at the same age group, respectively, for anti-HCV, was 0.59% of 30-39 years old, 1.79% of 40-49 years old, 0.98% of 50-59 years old. For HEY-IgG was 3.48% of < or =9 years old, 6.05% of 10-19 years old, 8.53% of 20-29 years old, 19.29%-21.67% of 30- > or =60 years old.
CONCLUSIONS: The inoculation againt HAY and HBY is enhanced in the youngster population. HBsAg carrier and UCY infection is decreasing. The HEY infection in the Hid people is lower than the Han nationality.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20387483

Source DB:  PubMed          Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi        ISSN: 1003-9279


  1 in total

1.  Eight-year seroprevalence of HBV, HCV and HIV in Diyarbakir training and research hospital.

Authors:  Mine Turhanoğlu; Arzu Onur; Fulya Bayındır Bilman; Zeynep Ayaydın; Gülseren Samancı Aktar
Journal:  Int J Med Sci       Date:  2013-09-12       Impact factor: 3.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.